Literature DB >> 15580958

A new nonadride derivative, dihydroepiheveadride, as characteristic antifungal agent against filamentous fungi, isolated from unidentified fungus IFM 52672.

Tomoo Hosoe1, Kazutaka Fukushima, Takeshi Itabashi, Koohei Nozawa, Kayoko Takizawa, Kaoru Okada, Galba Maria de Campos Takaki, Ken-ichi Kawai.   

Abstract

In the screening of searching for new antifungal agents, a new nonaride compound, dihydroepiheveadride (1), was isolated from unidentified fungus IFM 52672 as the most potent antifungal principle from this organism. The structure of 1 was established on the basis of spectroscopic and chemical investigation, as well as detailed comparison of the spectroscopic and physico-chemical data of the oxidized derivative (3) from 1 with those of heveadride (2). Compound 1 showed strong antifungal activity against various filamentous fungi including human pathogens Aspergillus fumigatus, Penicillium marneffei and Trichophyton spp. It also showed the growth inhibition activity against certain human pathogenic yeasts such as Trichosporon species, while it had weak or no antifungal activity against Candida spp. and Cryptococcus neoformans, and no antibacterial activity against Bacillus subtilis nor against Escherichia coli. The antifungal potencies of compounds 2 and 3 were found to be weaker than that of 1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15580958     DOI: 10.7164/antibiotics.57.573

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

1.  In silico analyses of maleidride biosynthetic gene clusters.

Authors:  Katherine Williams; Kate M J de Mattos-Shipley; Christine L Willis; Andrew M Bailey
Journal:  Fungal Biol Biotechnol       Date:  2022-02-17

2.  Epipolythiodiketopiperazines from the Marine Derived Fungus Dichotomomyces cejpii with NF-κB Inhibitory Potential.

Authors:  Henrik Harms; Barbora Orlikova; Seungwon Ji; Damun Nesaei-Mosaferan; Gabriele M König; Marc Diederich
Journal:  Mar Drugs       Date:  2015-08-06       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.